We have to remember the market cap hit over $300m last year purely on the basis of CEO change, possibly with the thought of a more speedy, more definitive path forward. I think the technical path forward is clear, the commercial not so, but it does hinge on the technical outcomes.
in saying that the decision to go depression vs Fragile. X was a commercial one, that could be a bigger market than the aspects of AD we are targeting.
This stock could go anywhere, another rise to $300m or even an IMU market cap.
Its all speculative until we get big pharma interest.
ACW up +21% in last 6 months , up +54% YTD, good upside momentum into 2024 & 2025 results, page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
-0.002(6.45%) |
Mkt cap ! $78.66M | |||
| Open | High | Low | Value | Volume |
| 3.1¢ | 3.1¢ | 2.8¢ | $201.5K | 6.782M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 3242472 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 1827387 | 2 |
View Market Depth
| Last trade - 16.10pm 20/09/2024 (20 minute delay) ? |
| ACW (ASX) Chart |